Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134123) titled 'Integrated Single-cell and Transcriptomic Profiling Identifies Radiothera... Read More
Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134127) titled 'Effects of preemptive paravertebral blockade with liposomal bupivacaine o... Read More
Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134131) titled 'Development of a general visual foundation model for ophthalmic surgeries... Read More
Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134135) titled 'Differential Neural Facilitation Effects between Grasping and Extension M... Read More
Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134138) titled 'Construction and Validation of a Machine Learning-Based Predictive Model ... Read More
Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134141) titled 'A Prospective, Single-Arm, Phase II Clinical Study of Neoadjuvant Sintili... Read More
Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134144) titled 'Remimazolam vs propofol on postoperative myocardial injury in elderly sur... Read More
Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134147) titled 'Efficacy and safety of ipilimumab in combination with bevacizumab as firs... Read More
Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134150) titled 'Development and Validation of a Contrast-Induced Acute Kidney Injury Risk... Read More
Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134152) titled 'Transformative Study of Orelabrutinib Combined with Pola-R-CHP Regimen in... Read More